-
Fenofibrate PPARα Agonist Workflows
2026-09-15
Fenofibrate provides a practical bridge between lipid metabolism research, hepatic growth signaling, and cancer biology research. This guide translates PPARα–YAP evidence into reproducible cell, pathway, and animal-study workflows with concentration, solubility, and troubleshooting guidance.
-
HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus
2026-09-15
The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus supports in vitro transcription of randomly Cy3-modified RNA probes for fluorescence-based workflows, including in situ hybridization and Northern blotting. It is intended for research use only and should not be used for diagnostic, medical, or therapeutic applications.
-
TRIB3, Ferroptosis, and Sunitinib Response in ccRCC
2026-09-14
The reference study identifies TRIB3 as a regulator of sunitinib response in clear cell renal cell carcinoma and links its depletion to ferroptosis through the SLC7A11/GPX4 axis. Its integrated bioinformatic and cellular approach provides a mechanistic rationale for investigating TRIB3 suppression as a strategy to address acquired drug resistance, while remaining preclinical.
-
MLN2238 Proteasome β5 Inhibition: Applied Workflows
2026-09-14
MLN2238 enables controlled chymotrypsin-like proteasome inhibition for apoptosis, proteostasis, and drug-resistance studies. This practical guide connects β5-focused dose design with ROS–JNK–CREB readouts highlighted in Drosophila and 293T research.
-
BKT140: Designing CXCR4 Functional Assays
2026-09-13
BKT140 (BL-8040) is a CXCR4 antagonist that connects receptor biology with tumor migration, apoptosis, and stem cell mobilization assays. This article presents an assay-first framework for translating CXCR4 expression into interpretable oncology research decisions.
-
Recombinant Mouse Sonic Hedgehog: A Comparative Assay Lens
2026-09-12
Recombinant Mouse Sonic Hedgehog can do more than confirm pathway activation: it can help separate ligand sufficiency, tissue competence, and species-specific developmental regulation. This article uses a recent comparative genital-tubercle study to develop a rigorous framework for interpreting SHH protein experiments.
-
Steroid Lysis of Protoplasts: Methods and Findings
2026-09-12
Smith and Shay used lysozyme-generated protoplasts of Sarcina lutea to distinguish membrane-disruptive steroid activity from effects attributable to the bacterial cell wall. Their protection and surfactant experiments showed that polyamines, divalent cations, aggregation, and membrane-active additives could markedly alter lysis, supporting a primarily membrane-centered mechanism.
-
Pifithrin-α (PFTα): Reliable p53 Assays
2026-09-11
Learn how Pifithrin-α (PFTα), SKU A4206, can clarify p53-dependent apoptosis, ferroptosis, and post-irradiation cell-cycle responses in viability and cytotoxicity workflows. This scenario-based guide covers assay design, solvent handling, controls, interpretation, and practical supplier selection.
-
CQ3196: Oral RIOK2 Inhibition in Cancer
2026-09-11
The reference study describes a medicinal-chemistry optimization of the RIOK2 inhibitor CQ211 that produced CQ3196, a potent 4-methoxy-triazoloquinoline with oral bioavailability. CQ3196 combined nanomolar RIOK2 binding, inhibition of gastric cancer cell proliferation, measurable oral exposure, and antitumor activity in an HGC-27 xenograft model, supporting further preclinical evaluation.
-
PBS Liposomes as Causal Controls in Depletion Studies
2026-09-10
PBS Liposomes provide more than a routine negative control: they help separate macrophage uptake, liposome exposure, and clodronate-specific cytotoxicity. This article combines assay design principles with structural insights from TRPM3 research to improve causal interpretation in in vivo macrophage depletion studies.
-
DPPH Antioxidant Screening: Workflow & Troubleshooting
2026-09-10
Build a reproducible DPPH workflow for rapid in vitro antioxidant screening, natural product comparison, and high-throughput prioritization. This guide connects colorimetric radical scavenging data with the wild-versus-cultivated Taihangia rupestris study and shows how to avoid common solvent, matrix, and endpoint errors.
-
IPA-3 Workflows for Selective Pak1 Research
2026-09-09
IPA-3 supports mechanism-focused Pak1 autophosphorylation inhibition, kinase activity assays, and cell-based pathway studies without relying on ATP-site competition. This guide connects practical Pak1 workflows with carefully bounded applications in cancer biology research, neuroinflammation, and exploratory HIV-1 cell-contact assays.
-
Separating Growth Inhibition from Cancer Cell Death
2026-09-09
Hannah Schwartz’s dissertation shows why in vitro cancer-drug studies should distinguish reduced relative viability from true fractional cell killing. Its central contribution is a framework for interpreting growth inhibition, death, and their timing as related but non-equivalent components of drug response.
-
ABT-263 (Navitoclax) Apoptosis Workflow
2026-09-08
Build more informative apoptosis assays with ABT-263 (Navitoclax), combining Bcl-2 family perturbation with caspase, mitochondrial, and viability readouts. A practical workflow also shows how NRF1-based mitochondrial studies can sharpen interpretation without overstating evidence across cancer and stem-cell models.
-
Phosbind Biotin LC: Practical Western Blot Guide
2026-09-08
Phosbind Biotin LC is a phosphate-binding reagent for detecting phosphorylated proteins on PVDF membranes when phospho-specific antibodies are unavailable or unsuitable. It should be used in membrane-based Western Blot workflows with streptavidin-HRP and chemiluminescent detection, not in aqueous-only assays or workflows that require long-term storage of working solutions.